Stocks
Colgate-Palmolive Company Financial Statements (CL) |
||||||||||
| Colgate-Palmolive Companysmart-lab.ru | % | 2022 | 2022 | 2023 | LTM ? | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 30.06.2022 | 30.09.2022 | 31.12.2022 | 16.02.2023 | 15.02.2024 | 26.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 17 967 | 17 967 | 19 457 | 19 752 | |||||
| Operating Income, bln rub | 3 614 | 4 335 | 4 131 | 4 299 | ||||||
| EBITDA, bln rub | ? | 2 870 | 4 880 | 4 698 | 4 599 | |||||
| Net profit, bln rub | ? | 1 785 | 1 785 | 2 300 | 2 611 | |||||
| OCF, bln rub | ? | 2 556 | 2 556 | 3 745 | 3 691 | |||||
| CAPEX, bln rub | ? | 696.0 | 696.0 | 705.0 | 668.0 | |||||
| FCF, bln rub | ? | 1 860 | 1 860 | 3 040 | 3 023 | |||||
| Dividend payout, bln rub | 1 691 | 1 691 | 1 749 | 1 753 | ||||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 94.7% | 94.7% | 76.0% | 67.1% | ||||||
| OPEX, bln rub | 6 634 | 6 634 | 7 120 | 7 273 | ||||||
| Cost of production, bln rub | 7 719 | 7 719 | 8 206 | 8 109 | ||||||
| R&D, bln rub | 0.000 | 320.0 | 343.0 | 343.0 | ||||||
| Interest expenses, bln rub | 153.0 | 167.0 | 299.0 | 236.0 | ||||||
| Assets, bln rub | 15 711 | 16 288 | 15 731 | 15 731 | 16 393 | 16 571 | ||||
| Net Assets, bln rub | ? | 168.0 | 622.0 | 401.0 | 401.0 | 609.0 | 230.0 | |||
| Debt, bln rub | 7 986 | 8 248 | 8 766 | 8 899 | 9 064 | 8 689 | ||||
| Cash, bln rub | 858.0 | 938.0 | 775.0 | 775.0 | 1 145 | 1 310 | ||||
| Net debt, bln rub | 7 128 | 7 310 | 7 991 | 8 124 | 7 919 | 7 379 | ||||
| Ordinary share price, rub | 80.1 | 70.3 | 78.8 | 78.8 | 79.7 | 74.8 | ||||
| Number of ordinary shares, mln | 836.4 | 836.4 | 827.4 | 822.8 | ||||||
| Market cap, bln rub | 0 | 0 | 65 900 | 65 900 | 65 952 | 61 562 | ||||
| EV, bln rub | ? | 7 128 | 7 310 | 73 891 | 74 024 | 73 871 | 68 941 | |||
| Book value, bln rub | -5 384 | -5 135 | -4 871 | -4 871 | -4 688 | -4 948 | ||||
| EPS, rub | ? | 2.13 | 2.13 | 2.78 | 3.17 | |||||
| FCF/share, rub | 2.22 | 2.22 | 3.67 | 3.67 | ||||||
| BV/share, rub | -5.82 | -5.82 | -5.67 | -6.01 | ||||||
| EBITDA margin, % | ? | 16.0% | 27.2% | 24.1% | 23.3% | |||||
| Net margin, % | ? | 9.93% | 9.93% | 11.8% | 13.2% | |||||
| FCF yield, % | ? | 0.00% | 0.00% | 2.82% | 2.82% | 4.61% | 4.91% | |||
| ROE, % | ? | 0.00% | 0.00% | 445.1% | 445.1% | 377.7% | 1 135% | |||
| ROA, % | ? | 0.00% | 0.00% | 11.3% | 11.3% | 14.0% | 15.8% | |||
| P/E | ? | 36.9 | 36.9 | 28.7 | 23.6 | |||||
| P/FCF | 35.4 | 35.4 | 21.7 | 20.4 | ||||||
| P/S | ? | 3.67 | 3.67 | 3.39 | 3.12 | |||||
| P/BV | ? | 0.00 | 0.00 | -13.5 | -13.5 | -14.1 | -12.4 | |||
| EV/EBITDA | ? | 25.7 | 15.2 | 15.7 | 15.0 | |||||
| Debt/EBITDA | 2.78 | 1.66 | 1.69 | 1.60 | ||||||
| R&D/CAPEX, % | 0.00% | 46.0% | 48.7% | 51.3% | ||||||
| CAPEX/Revenue, % | 3.87% | 3.87% | 3.62% | 3.38% | ||||||
| Colgate-Palmolive Company shareholders | ||||||||||
